The inability to properly identify and localize small lesions can lead to inaccurate interpretation and unnecessary procedures, potentially increasing costs and risk for both the patient and healthcare providers.
By using the CT as the frame-of-reference for image reconstruction, xSPECT Bone™1 is able to extract a zone map with different tissue segments to delineate the boundaries of the nuclear uptake during SPECT reconstruction. Through this deep integration of SPECT and CT data, xSPECT Bone can help you clearly identify disease not easily seen with conventional SPECT.
And the need for costly CT, MR or biopsy follow-ups can potentially be reduced with xSPECT Bone, which offers higher image resolution and diagnostic relevance2.
The need to provide outcome-based medicine can lead to operational inefficiencies in scheduling and performing unnecessary procedures due to uncertain results.
The first automated, accurate and reproducible quantification for 99mTc, 123I, 177Lu3 and 111In, xSPECT Quant™4 extends advanced SPECT quantification from general nuclear medicine and bone studies to indications including neurological disorders, neuroendocrine tumors, neuroblastoma and prostate cancer.
xSPECT Quant is the first and only technology to use a 3% National Institute of Standards and Technology (NIST) traceable precision source5, enabling standardization of uptake values across different cameras, dose calibrators and facilities, for reliable disease detection and evaluation of therapy response.
The absolute quantification capabilities of xSPECT Quant also can facilitate theranostics, an emerging approach employing radioactive isotopes that emit energies to not only image but also treat the patient’s disease.
Broad QuantificationTM1 utilizes xSPECT ™1 technology for accurate images and reproducible quantification. It is built upon the core foundation of xSPECT technology.
With the use of workflow-guided manual calibrations, Broad Quantification integrates several xSPECT technology corrections during reconstruction of SPECT images to produce accurate images and reproducible quantitative values.
Broad Quantification may be utilized as a standalone quantification solution or in combination with xSPECT Quant to provide accurate and reproducible quantification for the nearly all isotopes and collimators used in your imaging facility.
Workflow-enhanced conventional quantification
Accuracy and reproducibility of quantitative values to the dose calibrator
For common SPECT isotopes and parallel-hole collimators
xSPECT, xSPECT Bone, xSPECT Quant and Broad Quantification are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
A. H. Vija, et al; “Evaluation of image quality and clinical acceptance of HD-Bone, a novel multimodal SPECT/CT reconstruction method for Tc99m diphosphonate imaging” - J Nucl Med. 2013; 54 (Supplement 2):339.
xSPECT Quant 177Lu is not commercially available in the US or all countries worldwide. 177Lu, referenced herein, is not currently recognized by the US FDA as being safe and effective, and Siemens does not make any claims regarding its use. Due to regulatory reasons, it’s future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
xSPECT Quant is not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.